BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Increase in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 3,200 shares, an increase of 52.4% from the August 15th total of 2,100 shares. Based on an average daily volume of 105,900 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Price Performance

Shares of NASDAQ:BCTXW opened at $0.19 on Friday. The stock’s 50-day moving average price is $0.21 and its two-hundred day moving average price is $0.66. BriaCell Therapeutics has a 12-month low of $0.11 and a 12-month high of $2.60.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.